COMP <GO>
LENZ vs TVGN // ALTMAN Z-SCORE & DEBT/EQUITY
LENZ Therapeutics Inc. (NASDAQ) VS. Tevogen Inc. (NASDAQ) • 15-METRIC TALLY: LENZ 3
— TVGN 1
■ METRIC PARITY
LAST: $3.05 (-12.61%) • MKT CAP: $95.8M
balance-sheet
2.19
LAST: $5.90 (-2.48%) • MKT CAP: $92.8M
balance-sheet
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LENZ VS. TVGN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LENZ | TVGN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 96.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -27.80% | -35.00% | +7.20 | LENZ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -13.02% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 2.19 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 1/9 | +2.00 | LENZ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 35.8 | 37.1 | -1.30 | TVGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $95.8M | $92.8M | $3.0M | LENZ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LENZ REV | TVGN REV | LENZ GROSS % | TVGN GROSS % | LENZ FCF | TVGN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $19.1M | $0 | 97.8% | — | -$70.0M | -$12.4M |
| FY 2024 | $0 | $0 | — | — | -$59.9M | -$12.0M |
| FY 2023 | $0 | $0 | — | — | -$60.4M | -$8.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LENZ // BETA —
TVGN // BETA —